Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

Press releases published on October 28, 2026

Oct. 28, 2026

Mineralys Therapeutics Announces Publication of Phase 2 Explore-CKD Trial Results for Lorundrostat in Kidney International

Indeterminate GlobeNewswire

Oct. 28, 2026

Axogen, Inc. Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 28, 2026

Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

Adagene Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte’s INCA33890 in Patients with Microsatellite Stable Colorectal Cancer

Indeterminate GlobeNewswire

Oct. 28, 2026

ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)

Indeterminate GlobeNewswire

Oct. 28, 2026

NovaBridge Biosciences Appoints Chuck Silberstein as Chief Financial Officer

Indeterminate GlobeNewswire

Oct. 28, 2026

Replimune Reports Fiscal Second Quarter 2027 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Oct. 28, 2026

Remix Therapeutics Selected for Late-Breaking Oral Presentation at the 38th EORTC-NCI-AACR Symposium

Indeterminate GlobeNewswire

Oct. 28, 2026

BPGbio Publishes Pioneering Research on Novel Brain-Penetrant Therapeutic Candidate for Glioma

Indeterminate GlobeNewswire

Oct. 28, 2026

Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income

Indeterminate GlobeNewswire

Oct. 28, 2026

Minerva Neurosciences to Host In-Person KOL Event to Discuss Roluperidone for Negative Symptoms of Schizophrenia

Indeterminate GlobeNewswire

Oct. 28, 2026

Beyond the Ballot: More Than 3,500 Back OHIP Petition as Psychotherapy Gaps Come Into Focus

Indeterminate GlobeNewswire

Oct. 28, 2026

Canadian Vaping Association Says Flavour Bans Are a Gift to the Illicit Market

Indeterminate GlobeNewswire

Oct. 28, 2026

Rapport Announces Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement

Indeterminate GlobeNewswire

Oct. 28, 2026

Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program

Indeterminate GlobeNewswire

Oct. 28, 2026

Nxera Pharma Secures Exclusive Rights to Fabry Disease Phase 3 Oral Therapy Candidate Lucerastat for Japan and Selected Asia Pacific Markets

Indeterminate GlobeNewswire

Oct. 28, 2026

Junshi Biosciences Announces Final Analysis Results of the Phase 3 NEOTORCH Study at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

15-year-old Designs Low-Cost Device to Monitor Airborne Bacteria in the Environment; Wins $25,000 Top Award at the 2026 Thermo Fisher Scientific Junior Innovators Challenge

Indeterminate GlobeNewswire

Oct. 28, 2026

Newsweek Places KFSH in Top 4% of World's Smart Hospitals for Digital Maturity and AI

Indeterminate GlobeNewswire